0001415889-22-001742.txt : 20220223 0001415889-22-001742.hdr.sgml : 20220223 20220223202345 ACCESSION NUMBER: 0001415889-22-001742 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220218 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moreland Mary K CENTRAL INDEX KEY: 0001783147 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 22665941 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-02232022_050234.xml X0306 4 2022-02-18 0000001800 ABBOTT LABORATORIES ABT 0001783147 Moreland Mary K 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false EXECUTIVE VICE PRESIDENT Common shares without par value 2022-02-18 4 A 0 15813 0 A 88158 D Common shares without par value 2022-02-22 4 F 0 793 116.79 D 87365 D Common shares without par value 2021-02-22 4 S 0 400 119.3067 D 86965 D Common shares without par value 10986 I Profit Sharing Trust Option (right to buy) 117.58 2022-02-18 4 A 0 73696 0 A 2023-02-18 2032-02-17 Common Shares 73696 73696 D These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.3003 to $119.3100, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2022. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 24,565 on February 18, 2023, 24,565 on February 18, 2024, and 24,566 on February 18, 2025. The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). /s/ Mary K. Moreland by Jessica H. Paik, Attorney-in-Fact 2022-02-23